SCHEMBL30582601

SCHEMBL30582601

Cn1c(C2=CCC3(CCNCC3)CC2)c(-c2cccnc2)c2c(N)ncnc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.40
▸ PIK3CG P48736 3/20 0.40
▸ PI4KB Q9UBF8 2/20 0.40
▸ EGFR P00533 2/20 0.40
▸ SRC P12931 2/20 0.40
▸ PIK3CA P42336 2/20 0.40
▸ PIK3CB P42338 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ HCK P08631 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ EPHB4 P54760 1/20 0.40
▸ PRKDC P78527 1/20 0.40
▸ LRRK2 Q5S007 1/20 0.37
▸ RET P07949 2/20 0.37
▸ GSK3B P49841 3/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ PI4KA P42356 1/20 0.33
▸ PI4K2B Q8TCG2 1/20 0.33
▸ PI4K2A Q9BTU6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26105782 1.00 PIK3CD (0.40) PIK3CDPIK3CGPI4KBEGFRSRC
SCHEMBL26107963 0.85 LRRK2 (0.34) LRRK2RETDYRK1ACCNT1CDK9
SCHEMBL26109630 0.85 RIPK2 (0.40) PIK3CDPIK3CGPI4KBEGFRSRC
SCHEMBL26105963 0.85 CCNT1 (0.34) PIK3CDPIK3CGEGFRSRCPIK3CA
SCHEMBL30582633 0.85 CCNT1 (0.34) PIK3CDPIK3CGPI4KBEGFRSRC
SCHEMBL30582608 0.85 CCNT1 (0.34) PIK3CDPIK3CGEGFRSRCPIK3CA
SCHEMBL30582620 0.85 RIPK2 (0.40) PIK3CDPIK3CGPI4KBEGFRSRC
SCHEMBL26106109 0.85 CCNT1 (0.34) PIK3CDPIK3CGPI4KBEGFRSRC
SCHEMBL26107955 0.84 RET (0.37) PIK3CDPIK3CGPI4KBEGFRSRC
SCHEMBL30582605 0.84 CCNT1 (0.38) PIK3CDPIK3CGPI4KBEGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback